Treatment options for uncomplicated community-acquired skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus: Oral antimicrobial agents

Surgical Infections

Volumn 9, Issue SUPPL. 1, 2008, Pages

  Zervos, Marcus ^a  

^a Henry Ford Health System Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; LINEZOLID; MACROLIDE; MINOCYCLINE; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BODY FLUID; BONE MARROW SUPPRESSION; CLINICAL TRIAL; DISEASE PREDISPOSITION; DRUG ANTAGONISM; DRUG HYPERSENSITIVITY; HEPATITIS; HUMAN; HYPERPIGMENTATION; HYPERSENSITIVITY REACTION; KERNICTERUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PHOTOSENSITIVITY; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; REVIEW; SIDE EFFECT; SKIN ALLERGY; SKIN INFECTION; SOFT TISSUE INFECTION; STEVENS JOHNSON SYNDROME; TOOTH DISCOLORATION; TOXIC EPIDERMAL NECROLYSIS; VERTIGO;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; CARRIER STATE; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 53749088395     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2008.065.supp     Document Type: Review

References (24)

1. Stevens DL, Bisno AL, Chambers HF, et al.; Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005;41:1373-1406.
2. Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: Implications for patients and practitioners. Am J Clin Dermatol 2007;8:259-270.
3. Kowalski TJ, Berbari EF, Osmon DR. Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clin Proc 2005;80:1201-1207.
4. Ruhe JJ, Smith N, Bradsher RW, Menon A. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: Impact of antimicrobial therapy on outcome. Clin Infect Dis 2007;44:777-784.
5. Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA; CDC-Convened Experts' Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community: Summary of an experts' meeting convened by the Centers for Disease Control and Prevention. 2006. Available at http://198.246.98.21/ncidod/dhqp/pdf/ar/CAMRSA_ExpMtgStrategies.pdf. Accessed March 10, 2008.
6. Lewis JS 2nd, Jorgensen JH. Inducible clindamycin resistance in staphylococci: Should clinicians and microbiologists be concerned? Clin Infect Dis 2005;40:280-285.
7. Kaka AS, Rueda AM, Shelburne SA 3rd, et al. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2006;58:680-683.
8. Ruhe JJ, Monson T, Bradsher RW, Menon A. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: Case series and review of the literature. Clin Infect Dis 2005;40:1429-1434.
9. Ruhe JJ, Menon A. Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2007;51:3298-3303.
10. Cenizal MJ, Skiest D, Luber S, et al. Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2007;51:2628-2630.
11. Huang H, Flynn NM, King JH, et al. Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. J Clin Microbiol 2006;44:2423-2427.
12. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and healthcare-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976-2984.
13. Weber JT. Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2005;41(Suppl 4):S269-S272.
14. Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med 1992;117:390-398.
15. Talbot GH, Bradley J, Edwards JE Jr, et al; Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Bad bugs need drugs: An update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006;42:657-668.
16. National Institute of Allergy and Infectious Diseases. New Contracts Support Clinical Trials on Antibiotic-Resistant, Community-Acquired Staph Infections [NIAID Web site]. August 9, 2007. Available at http://www3.niaid.nih. gov/news/newsreleases/2007/ca-mrsa_contracts.htm. Accessed April 1, 2008.
17. National Institute of Allergy and Infectious Diseases. Confronting the Challenge of Antimicrobial Resistance [NIAID Web site]. March 10, 2008. Available at http://www.nih.gov/news/health/mar2008/niaid-10.htm. Accessed April 1, 2008.
18. Marcotte AL, Trzeciak MA. Community-acquired methicillin-resistant Staphylococcus aureus: An emerging pathogen in orthopaedics. J Am Acad Orthop Surg 2008;16:98-106.
19. Merlino JI, Malangoni MA. Complicated skin and soft-tissue infections: Diagnostic approach and empiric treatment options. Cleve Clin J Med 2007;74(Suppl 4):S21-S28.
20. DiNubile MJ, Lipsky BA. Complicated infections of skin and skin structures: When the infection is more than skin deep. J Antimicrob Chemother 2004;53(Suppl 2):ii37-ii50.
21. Vinh DC, Embil JM. Rapidly progressive soft tissue infections. Lancet Infect Dis 2005;5:501-513.
22. Bickels J, Ben-Sira L, Kessler A, Wientroub S. Primary pyomyositis. J Bone Joint Surg Am 2002;84-A:2277-2286.
23. Wendt C, Schinke S, Württemberger M, et al. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: A randomized, placebo-controlled, double-blind clinical trial. Infect Control Hosp Epidemiol 2007;28:1036-1043.
24. Simor AE, Phillips E, McGeer A, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007;44:178-185.